Affordable Access

Publisher Website

7 Methyl indole ethyl isothiocyanate causes ROS mediated apoptosis and cell cycle arrest in endometrial cancer cells

Gynecologic Oncology
DOI: 10.1016/j.ygyno.2012.04.041
  • Isothiocyanate (Itc)
  • Endometrial Cancer
  • Apoptosis
  • Cell Cycle Arrest
  • Reactive Oxygen Species (Ros)
  • Mitogen Activated Protein Kinases (Map Kinase)
  • Biology
  • Medicine


Abstract Objective Chemotherapy options for advanced endometrial cancer are limited and newer therapeutic agents are urgently needed. This study describes the therapeutic potential of 7 Methyl-indole ethyl isothiocyanate (7Me-IEITC) in endometrial cancer cell lines. Methods 7Me-IEITC was synthesized in our laboratory. The cell viability of 7Me-IEITC treated ECC-1 and KLE endometrial cancer cell was determined by MTS assay. Morphology and apoptosis were further confirmed by DAPI-staining and TUNEL assay. The measurement of reactive oxygen species (ROS), mitochondrial transmembrane depolarization potential (ΔΨm) and cell cycle phase was determined by FACS analysis. Expression of proteins involved in apoptosis, survival and cell-cycle progression was analyzed by Western blotting. Results 7Me-IEITC reduced the viability of the ECC-1 and KLE cancer cell-lines (IC50~2.5–10μM) in a dose dependent fashion. 7Me-IEITC treatment caused mitochondrial transmembrane potential reduction, elevated the production of ROS, leading to activation of apoptosis in endometrial cancer KLE and ECC-1 cells. 7Me-IEITC treatment activated Bad, suppressed Bcl2 phosphorylation followed by PARP-1 deactivation and caspase 3 and 7 activation. 7Me-IEITC treatment arrested the progression of KLE cells in S-phase and caused CDC25 and cyclin-D1 downregulation. Pre-treatment with ascorbic acid abrogated 7Me-IEITC induced apoptosis in ECC-1 and KLE cells, suggesting that 7Me-IEITC mediated cytotoxicity is primarily through ROS production. Conclusion 7Me-IEITC demonstrated promising cytotoxic effects in endometrial cancer cell line model.

There are no comments yet on this publication. Be the first to share your thoughts.